Last week, our CEO, Christian Kanstrup, joined the Life Sciences Investor Forum to present Evaxion’s clinically validated AI-Immunology™ platform, highlighting our extensive pipeline of novel vaccine candidates in cancer and infectious diseases and discussing our strategic approach to partnerships.
By Life Sciences Investor Forum